Kaukopohjan Ns Ruovesi Saija Tuupanen & eXmiehet Tyrnvn Seurojentalo Tyrnv Ma 19.10.26 Matti Oksa M/S Finlandia Helsinki Ti 20.10.26 Matti Oksa M/S Finlandia Helsinki Energia M/S Finlandia Helsinki Isto Hiltunen M/S Finlandia Helsinki Ke 21.10.26 Matti Oksa M/S Finlandia Helsinki Hovimuusikko Ilkka M/S Finlandia Helsinki To 22.10.26 Matti Oksa M/S Finlandia Helsinki Isto Hiltunen Finnlines, Naantali Pe 23.10.26 Matti Oksa M/S Finlandia Helsinki Anneli Mattila & Recados Kunnonpaikka Siilinjrvi Bat & Ryyd Ravintola Takatasku Joensuu Hurma Ruusulinna Nurmijrvi Janne Raappana Ruusulinna Nurmijrvi Janne Tulkki & Tulinen Sydn Hotelli Keurusselk Keuruu Kovaa ajoa Lohja Spa & Resort Karjalohja - Lohja Pasi Kivimki & N.Y.T
It helps improve fine lines, acne scars, uneven texture, enlarged pores, and overall skin tone, leaving your complexion smoother, firmer, and more radiant with minimal downtime
Existing NICE-approved therapies, including semaglutide and tirzepatide, already offer substantial benefits for eligible patients and are available through NHS pathways
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
The product was applied twice daily, morning and evening, on the face, dcollet, and neck
In addition, both peptides form multiple hydrophobic interactions with the TM1 residues of GLP-1R